143 related articles for article (PubMed ID: 2165793)
1. DNA topoisomerases.
Hsieh T
Curr Opin Cell Biol; 1990 Jun; 2(3):461-3. PubMed ID: 2165793
[No Abstract] [Full Text] [Related]
2. The role of DNA topoisomerases in recombination and genome stability: a double-edged sword?
Wang JC; Caron PR; Kim RA
Cell; 1990 Aug; 62(3):403-6. PubMed ID: 2165864
[No Abstract] [Full Text] [Related]
3. DNA topoisomerases: from a laboratory curiosity to a subject in cancer chemotherapy.
Wang JC
NCI Monogr; 1987; (4):3-6. PubMed ID: 2819727
[TBL] [Abstract][Full Text] [Related]
4. New mechanistic and functional insights into DNA topoisomerases.
Chen SH; Chan NL; Hsieh TS
Annu Rev Biochem; 2013; 82():139-70. PubMed ID: 23495937
[TBL] [Abstract][Full Text] [Related]
5. Topoisomerases in human disease.
Epstein RJ
Lancet; 1988 Mar; 1(8584):521-4. PubMed ID: 2893929
[TBL] [Abstract][Full Text] [Related]
6. Recent studies of DNA topoisomerases.
Wang JC
Biochim Biophys Acta; 1987 Jun; 909(1):1-9. PubMed ID: 3034331
[No Abstract] [Full Text] [Related]
7. DNA topoisomerases and topoisomerase inhibitors.
Giaccone G
Pathol Biol (Paris); 1994 Apr; 42(4):346-52. PubMed ID: 7808789
[TBL] [Abstract][Full Text] [Related]
8. Symposium: downstream from topoisomerase-DNA lesions: life-or-death consequences for the cell.
Kohn KW; Andoh T
Cell Biochem Biophys; 2000; 33(2):171-3. PubMed ID: 11325036
[No Abstract] [Full Text] [Related]
9. Yeast systems for demonstrating the targets of anti-topoisomerase II agents.
Nitiss JL; Nitiss KC
Methods Mol Biol; 2001; 95():315-27. PubMed ID: 11089243
[No Abstract] [Full Text] [Related]
10. [DNA supercoiling and topoisomerases in Escherichia coli].
Gómez-Eichelmann MC; Camacho-Carranza R
Rev Latinoam Microbiol; 1995; 37(3):291-304. PubMed ID: 8850348
[TBL] [Abstract][Full Text] [Related]
11. DNA topoisomerases as targets for the anticancer drug TAS-103: primary cellular target and DNA cleavage enhancement.
Byl JA; Fortune JM; Burden DA; Nitiss JL; Utsugi T; Yamada Y; Osheroff N
Biochemistry; 1999 Nov; 38(47):15573-9. PubMed ID: 10569941
[TBL] [Abstract][Full Text] [Related]
12. Unknotting the complexities of multidrug resistance: the involvement of DNA topoisomerases in drug action and resistance.
Beck WT
J Natl Cancer Inst; 1989 Nov; 81(22):1683-5. PubMed ID: 2553990
[No Abstract] [Full Text] [Related]
13. Mitotic recombination in the rDNA of S. cerevisiae is suppressed by the combined action of DNA topoisomerases I and II.
Christman MF; Dietrich FS; Fink GR
Cell; 1988 Nov; 55(3):413-25. PubMed ID: 2902925
[TBL] [Abstract][Full Text] [Related]
14. Isolation of covalent enzyme-DNA complexes.
Rowe TC; Grabowski D; Ganapathi R
Methods Mol Biol; 2001; 95():129-35. PubMed ID: 11089226
[No Abstract] [Full Text] [Related]
15. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
16. DNA topoisomerases--new twists to tumour therapy.
Lancet; 1988 Mar; 1(8584):512-3. PubMed ID: 2893923
[No Abstract] [Full Text] [Related]
17. Analysis of eukaryotic DNA topoisomerases and topoisomerase-directed drug effects.
Boege F
Eur J Clin Chem Clin Biochem; 1996 Nov; 34(11):873-88. PubMed ID: 8960461
[TBL] [Abstract][Full Text] [Related]
18. ICE bioassay. Isolating in vivo complexes of enzyme to DNA.
Subramanian D; Furbee CS; Muller MT
Methods Mol Biol; 2001; 95():137-47. PubMed ID: 11089227
[No Abstract] [Full Text] [Related]
19. Multiple bacterial topoisomerases: specialization or redundancy?
Schmid MB; Sawitzke JA
Bioessays; 1993 Jul; 15(7):445-9. PubMed ID: 8397515
[TBL] [Abstract][Full Text] [Related]
20. The DNA binding, cleavage, and religation reactions of eukaryotic topoisomerases I and II.
Andersen AH; Svejstrup JQ; Westergaard O
Adv Pharmacol; 1994; 29A():83-101. PubMed ID: 7826866
[No Abstract] [Full Text] [Related]
[Next] [New Search]
